Alpha Cognition operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 6.75 and a current ratio of 1.32, indicating moderate liquidity risk. The company's pri…
CAI.O maintains a strong liquidity position, with cash and equivalents amounting to $796.27 million, significantly exceeding its total liabilities of $548.36 million, resulting in a current ratio o…
Covalon maintains a strong liquidity position, with a current ratio of 6.8 and $7.26 million in cash and equivalents, which is well above the industry median. The company's liquidity FPT (free cash…
Fusion Antibodies operates with a fully diluted share count of 125,021,878 shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock…
IDHC.L maintains a relatively strong liquidity position, with a current ratio of 1.46, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's…
Klaria Pharma Holding AB (publ) has a market capitalization of 3.92 billion SEK and a price-to-book ratio of 134.33, indicating a highly leveraged equity valuation relative to its book value. The c…
MKDWELL Tech Inc has a highly leveraged capital structure, with total liabilities of 122.3 million USD and total equity of -27.2 million USD, resulting in a negative debt-to-equity ratio of -3.57.…
MeCure Industries PLC has a debt-to-equity ratio of 2.79, indicating a capital structure that is heavily leveraged, with long-term debt accounting for a significant portion of its total liabilities…
Medical Developments International Ltd has a market capitalization of AUD 43.94 million, with a current market price of AUD 0.39 per share. The company has 112,658,324 basic and diluted shares outs…
Nasus Pharma has a market capitalization of $34.78 million, with a current market price of $2.97 per share. The company has 11.71 million shares outstanding, with no dilution from potential share i…
The company's capital structure is characterized by a debt-to-equity ratio of 0.58, indicating a moderate level of leverage. Despite a negative operating income of -40,328,000 NZD, the company repo…
Progyny maintains a strong liquidity position with $112.2 million in cash and equivalents, representing 15.1% of total assets, and a current ratio of 2.73, well above the industry median of 1.4. Th…
Ramkhamhaeng Hospital PCL maintains a debt-to-equity ratio of 0.84, indicating a moderate level of leverage, and a current ratio of 0.45, suggesting potential liquidity constraints. The company's l…
Sanofi Consumer Healthcare India Ltd maintains a strong liquidity position, with a current ratio of 3.85 and cash and equivalents amounting to INR 3.75 billion, which significantly exceeds its tota…
Theriva Biologics Inc has a market capitalization of $14.73 million and a price-to-book ratio of 0.53, indicating that the company is trading at a significant discount to its book value. The compan…
Aesthetic Connect PCL maintains a strong capital structure with a debt-to-equity ratio of 0.01, indicating minimal leverage and a conservative financing approach. The company's liquidity position i…
Turn Therapeutics has a market capitalization of $119.75 million, with a current market price of $4.02 per share. The company has 29,788,040 basic and diluted shares outstanding, indicating no imme…
VOXP.WA maintains a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure, and a current ratio of 1.4, suggesting moderate liquidity. However, the company's net cash…
Canopy Growth Corp has a debt-to-equity ratio of 0.67 and a current ratio of 3.12, indicating moderate leverage and strong short-term liquidity. However, the company's cash and equivalents amount t…
Dong-A Socio Holdings Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as med…
The company's capital structure is characterized by a debt-to-equity ratio of 0.72, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
1345.HK maintains a strong liquidity position, with a current ratio of 3.22 and cash and equivalents of 166.6 million CNY, indicating the company can easily cover its short-term obligations. The co…
The company maintains a debt-to-equity ratio of 0.51, indicating a moderate level of leverage, and a current ratio of 1.44, suggesting it has sufficient short-term assets to cover its short-term li…
Luye Pharma Group Ltd has a basic and diluted share count of 3,994,515,953, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to…
Structure and Liquidity Abbisko Cayman Ltd has a basic and diluted share count of 716.46 million shares, indicating no immediate dilution pressure from share-based compensation or convertible instr…
Jiangxi Rimag Group Co Ltd has a market capitalization of 3.07 billion CNY, with a market price of 7.77 CNY per share. The company has no dilution risk, as the number of basic and diluted shares ou…
Guangzhou Innogen Pharmaceutical Group Co Ltd has a market capitalization of 5.46 billion CNY, with a market price of 11.96 CNY per share. The company has 456.82 million shares outstanding, with no…
Shanxi Zhendong Pharmaceutical Co Ltd has a market capitalization of 5.08 billion CNY and a price-to-book ratio of 1.52, indicating that the market values the company at a moderate premium to its b…
The company maintains a strong liquidity position, with a current ratio of 6.58 and cash and equivalents amounting to 3,213,173,790 KRW. The price-to-book ratio is 5.5, indicating that the market v…
RaQualia Pharma Inc maintains a capital structure with a debt-to-equity ratio of 0.68, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a curre…
SymBio Pharmaceuticals maintains a strong liquidity position, with cash and equivalents amounting to ¥6.36 billion, representing 87.7% of total assets. The company's liquidity FPT (free cash flow t…
The company has a market price of 25.0 JPY and a market capitalization of 6,825,130,550 JPY, with a price-to-book ratio of 3.9 and a price-to-tangible-book ratio of 3.9. The enterprise value to EBI…
The company maintains a strong liquidity position, with a current ratio of 7.03 and cash and equivalents amounting to 5,830,922,000 JPY, indicating a robust ability to meet short-term obligations.…
Artra Group Corp has a market price of 211 JPY per share, with a market capitalization of 2,166,280,874 JPY. The company's price-to-book ratio is 1.53, and its price-to-tangible-book ratio is also…
Internet Infinity Inc maintains a strong liquidity position with cash and equivalents amounting to 2,299,844,000 JPY, which is significantly higher than its total liabilities of 2,681,922,000 JPY,…
Living Platform Ltd has a liquidity position that is characterized by a current ratio of 1.08, indicating that the company has just enough current assets to cover its current liabilities. The compa…
The company maintains a strong liquidity position, with a current ratio of 14.44 and a cash and equivalents balance of 24,246,113,000 JPY, indicating a robust ability to meet short-term obligations…
ACMR.DH maintains a debt-to-equity ratio of 0.93, indicating a moderate reliance on debt financing, and a current ratio of 1.15, suggesting limited short-term liquidity cushion. The company's free…
AHC.AX maintains a strong liquidity position, with a current ratio of 1.56 and cash and equivalents amounting to 14.48 million AUD. The company's liquidity is further supported by a low debt-to-equ…
ALIKO.PA exhibits a weak capital structure and liquidity position, with a current ratio of 0.2 and a debt-to-equity ratio of 0.14. The company's free cash flow is negative at -1,001,330 EUR, and op…
Astrazeneca maintains a strong liquidity position with INR 5,093.30 crore in cash and equivalents, representing 33.55% of total assets. The company's liquidity FPT (free cash flow to total liabilit…
Structure and Liquidity BioVie has a market capitalization of $10.41 million and a price-to-book ratio of 0.67, indicating that the company is trading at a discount to its book value. The company's…
Geratherm Medical AG has a fully diluted share count of 5,411,945 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible s…
HLX.MI exhibits a low liquidity risk, with a current ratio of 2.76 and a cash and equivalents balance of 1,261,730 EUR, which is relatively modest compared to its total assets of 23,994,290 EUR. Th…
IIQ.AX has a strong liquidity position, with a current ratio of 5.75, indicating that it holds significantly more current assets than current liabilities. The company also maintains a substantial c…
Innate Pharma maintains a strong liquidity position, with EUR 113.9 million in cash and equivalents, which significantly exceeds its market capitalization of EUR 203.33 million. The company's enter…
MAP.AX has a liquidity position that is characterized by a current ratio of 1.87, indicating that the company has sufficient current assets to cover its current liabilities. However, the company's…
SVNS.L maintains a strong liquidity position, with cash and equivalents amounting to $1.72 billion, significantly exceeding its total liabilities of $1.39 billion. The company's debt-to-equity rati…
Vidac Pharma Holding PLC has a fully diluted share count of 56,946,204 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or converti…
Viromed Medical AG has a basic and diluted share count of 20.25 million shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. Howev…
Jiuzhitang maintains a strong liquidity position with a current ratio of 2.38, indicating the company can cover its short-term obligations more than twice over. However, the company has a net cash…
Andon Health maintains a strong liquidity position with a current ratio of 6.7, indicating a significant ability to cover short-term obligations with its current assets. However, the company's net…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. However, the liquidity risk is rated as medium, and the company…
SD Biosensor Inc has a liquidity position that appears to be medium risk, with a current ratio of 2.64 and a cash and equivalents balance of KRW 366.8 billion. However, the company's free cash flow…
China Isotope & Radiation Corp maintains a debt-to-equity ratio of 0.52, indicating a relatively conservative capital structure. The company's liquidity position is characterized by a current ratio…
Lepu Biopharma has a basic and diluted share count of 1.804 billion shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However,…
PegBio maintains a fully diluted share count of 391,091,532 shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock options or conv…
Fuan Pharmaceutical Group Co Ltd maintains a relatively strong liquidity position, with a current ratio of 2.32, indicating that it has more than twice the current assets to cover its current liabi…
Cosmo Bio maintains a strong liquidity position, with cash and equivalents amounting to ¥3.025 billion, representing 25.76% of total assets. The company's current ratio of 7.36 indicates a robust a…
DND PharmaTech Inc maintains a strong liquidity position, with a current ratio of 9.41, indicating that the company has significantly more current assets than current liabilities. The company's cas…
368A.T maintains a strong liquidity position with a current ratio of 11.99, indicating a high ability to meet short-term obligations. The company's cash and equivalents amount to 13.414 billion JPY…
Dr Sulaiman Al Habib Medical Services Group Company SJSC has a basic and diluted share count of 350,000,000 shares outstanding, indicating no dilution from stock options or convertible instruments.…
The company maintains a capital structure with a debt-to-equity ratio of 1.85, indicating a relatively high level of leverage. Its liquidity position is characterized by a current ratio of 1.05, su…
Nippon Chemiphar maintains a relatively strong liquidity position, with cash and equivalents of ¥9.2 billion, but its long-term debt of ¥16.98 billion exceeds its cash reserves, resulting in a nega…
Kusurinomadoguchi Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥2.1 billion, representing 17.3% of total assets. The company's liquidity FPT score of 4.02 indic…
Transcenta Holding Ltd has a basic and diluted share count of 452,858,499 shares outstanding, indicating no dilution from potential share-based compensation or convertible instruments. However, the…
Axe Compute Inc exhibits a highly leveraged equity structure, with a market price of $5.55 per share and a market capitalization of $30.74 million. The company's price-to-book ratio of 0.64 suggest…
ASG.V has a market capitalization of $18.15 million and an enterprise value to revenue ratio of 1.13, indicating a relatively low valuation compared to its revenue. The company's liquidity position…
Celyad's capital structure is characterized by a lack of dilution risk, as the number of basic and diluted shares outstanding is identical at 44,761,905, indicating no dilutive impact from stock op…
EKF Diagnostics has a fully diluted share count of 430.9 million, with no dilution observed between basic and diluted shares, indicating no material dilution risk from stock options or convertible…
ILA.AX has a highly liquid capital structure, as evidenced by a current ratio of 22.27, indicating that its current assets significantly exceed its current liabilities. The company is entirely equi…
SpyGlass Pharma maintains a strong liquidity position with $96.36 million in cash and equivalents, representing 83% of total assets. The company has no long-term debt and a current ratio of 12.67,…
Renhe Pharmacy maintains a strong liquidity position, with a current ratio of 5.24, indicating the company can easily cover its short-term obligations with its current assets. The company's liquidi…
Realcan Pharmaceutical Group Co Ltd has a debt-to-equity ratio of 0.9, indicating a moderate level of leverage. The company's liquidity is assessed as medium, with a current ratio of 1.09, suggesti…
JVM Co Ltd maintains a strong capital structure with a debt-to-equity ratio of 0.14, indicating a conservative leverage profile. The company's liquidity position is moderate, with a current ratio o…
CG MedTech has a market capitalization of 169,757,855,184 USD, with a market price of 1,644 USD per share. The company has 103,259,036 basic and diluted shares outstanding, indicating no immediate…
The company maintains a relatively strong liquidity position, with a current ratio of 2.6, indicating that it has sufficient current assets to cover its current liabilities more than twice over. Ho…
Brii Biosciences has a basic and diluted share count of 721.8 million, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liq…
Care Twentyone Corp has a highly leveraged capital structure, with a debt-to-equity ratio of 4.03, indicating a significant reliance on debt financing. The company's liquidity position is constrain…
Hybio Pharmaceutical Co Ltd has a debt-to-equity ratio of 3.12, indicating a high level of leverage, and a current ratio of 0.29, suggesting limited short-term liquidity. The company reported negat…
Protia Inc maintains a strong liquidity position, with a current ratio of 14.13, indicating a significant buffer of current assets over current liabilities. The company's cash and equivalents amoun…
Medical Net Inc has a liquidity position that appears robust, with cash and equivalents amounting to ¥1,528,258,000, which is a significant portion of its total assets of ¥3,989,574,000. The compan…
Starjoy Wellness and Travel Co Ltd has a market capitalization of 203.35 million CNY, with a market price of 0.28 CNY per share. The company has 726.25 million shares outstanding, with no dilution…
Taigen Biopharmaceuticals Holdings Ltd maintains a strong liquidity position, with a current ratio of 13.48, indicating a high ability to meet short-term obligations. The company's cash and equival…
Carna Biosciences Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥3,159.23 million, significantly exceeding its total liabilities of ¥376.25 million, resulting in…
The company maintains a strong liquidity position, with a current ratio of 38.76, indicating a substantial buffer of current assets over current liabilities. Its price-to-book ratio of 2.42 and pri…
Genoway's capital structure is characterized by a basic and diluted share count of 12,115,177 shares, indicating no immediate dilution pressure from share-based compensation or convertible instrume…
GBCS.PK exhibits a challenging capital structure, with a negative total equity of -$6,210,540 and a debt-to-equity ratio of -4.1, indicating a high reliance on debt financing. The company's liquidi…
LAXD.NS maintains a strong liquidity position, with a current ratio of 3.3 and cash and equivalents amounting to INR 610.93 million, which is significantly higher than the typical liquidity require…
NXTMH.HE has a debt-to-equity ratio of 0.99, indicating a balanced capital structure with moderate leverage. The company's liquidity is assessed as medium, with a current ratio of 1.27, suggesting…
Pointsbet Holdings Ltd has a basic and diluted share count of 347,586,582, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the ab…
Polaryx Therapeutics has a market capitalization of $161.44 million, with a current market price of $3.41 per share, and no dilution risk based on the current share count of 47.34 million shares ou…
VLG.L maintains a strong liquidity position with GBP 34.17 million in cash and equivalents, representing 34.5% of total assets, and a current ratio of 4.71, well above the industry median of 1.5. T…
Lanzhou Foci Pharmaceutical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 2.9, indicating that it has 2.9 times more current assets than current liabilities. Howe…
Chabiotech's capital structure is characterized by a high debt-to-equity ratio of 3.07, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium,…
Sinphar Pharmaceutical Co Ltd maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.44, indicating a moderate reliance on debt financing. The company's liquidity posit…
Yonghe Medical Group Co Ltd has a market capitalization of 1.16 billion CNY, with a current market price of 2.2 CNY per share. The company has 525.22 million shares outstanding, with no dilution fr…
The company maintains a market capitalization of 628.56 million CNY and a price-to-earnings ratio of 13.58, indicating a moderate valuation relative to its earnings. Its price-to-book ratio of 1.02…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.24, indicating a relatively low reliance on debt financing. Its liquidity position is characterized by a curr…
Shenyang Xingqi Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 1.86, indicating the company can cover its short-term liabilities with its short-term assets. Th…
The company maintains a strong liquidity position, with cash and equivalents amounting to 833,883,000 JPY, significantly exceeding its total liabilities of 426,092,000 JPY, as reflected in a curren…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥1,918,615,000, which significantly exceeds its total liabilities of ¥165,625,000, resulting in a current r…
The company's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ra…
Qingdao Vland Biotech Inc has a market capitalization of 3.31 billion CNY and a price-to-earnings ratio of 52.88, indicating a relatively high valuation compared to its earnings. The company's pric…
Uchiyama Holdings Co Ltd has a liquidity position that is currently medium, with a current ratio of 1.62, indicating the company can cover its short-term liabilities with its short-term assets. The…
6130.TWO has a liquidity position characterized by a current ratio of 3.09, indicating a strong ability to meet short-term obligations with its current assets. The company holds cash and equivalent…
Allergan Unlimited Co has a debt-to-equity ratio of 0.36, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidity position is char…
The company's capital structure is heavily leveraged, with total liabilities of EUR 6,711,790 and total equity of EUR -4,268,110, resulting in a debt-to-equity ratio of -1.16. Liquidity is constrai…
Arctic Minerals AB (publ) has a market capitalization of 389.86 million SEK and a price-to-book ratio of 3.48, indicating a premium valuation relative to its book value. The company's equity base s…
The company's capital structure is characterized by a debt-to-equity ratio of 0.79, indicating a moderate level of leverage. The liquidity position is marked by a current ratio of 1.55, suggesting…
Oncosil Medical Ltd has a fully diluted share count of 30,697,231 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible i…
The company maintains a capital structure with a debt-to-equity ratio of 1.19, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with free cash flow of…
Precision Optics Corporation Inc has a price-to-book ratio of 4.46, significantly above the industry median of 2.3, indicating a premium valuation relative to its tangible book value. The company's…
Zhejiang Hisoar Pharmaceutical Co Ltd has a debt-to-equity ratio of 0.26, indicating a relatively conservative capital structure with limited leverage. The company's current ratio of 1.28 suggests…
Tianjin Lisheng Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 4.37, indicating the company can easily cover its short-term liabilities with its short-term ass…
Cutia Therapeutics has a market capitalization of CNY 1.45 billion, with a current market price of CNY 4.00 per share, and no dilution risk based on the current share count of 363.37 million shares…
Qyuns Therapeutics has a market capitalization of 3.66 billion CNY, with a current market price of 16.28 CNY per share. The company's shares are fully diluted, with no additional shares outstanding…
YungShin Global Holding Corp maintains a strong capital structure with a debt-to-equity ratio of 0.14, indicating a relatively low reliance on debt financing. The company's liquidity position is ch…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2.81 billion, significantly exceeding its total liabilities of ¥170.95 million, resulting in a current rat…
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd maintains a conservative capital structure with a price-to-book ratio of 0.8 and a debt-to-equity ratio of 0.0, indicating minimal leverage. The…
Actinogen Medical Ltd operates with a fully diluted share count of 3,588,706,510 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options o…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of -1.36, indicating that liabilities significantly exceed equity. Liquidity is constrained, as evidenced by a curre…
Valbiotis has a basic and diluted share count of 23.66 million shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the c…
Chiang Mai Ram Medical Business PCL maintains a debt-to-equity ratio of 0.9, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a cu…
The company's capital structure is characterized by a strong equity base, with total equity of $9.34 million and no long-term debt, resulting in a debt-to-equity ratio of 0.00. The liquidity positi…
Mach7 Technologies Ltd has a market capitalization of approximately AUD 71.68 million, with a current market price of AUD 0.305 per share. The company's shares outstanding are 235,009,713, with no…
Pharmanutra SpA has a fully diluted share count of 9,575,183 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible i…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 3.91, indicating a significant reliance on debt financing. Its liquidity position is weak, as evidenced by a curr…
Synbiotic's capital structure is characterized by a lack of detailed liquidity metrics, as the company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going…
Sam Chun Dang Pharm Co Ltd has a relatively strong liquidity position, with a current ratio of 3.31, indicating that it holds more than three times as much in current assets as it does in current l…
Landfar Bio medicine Co Ltd has a market capitalization of 3,164,921,509.82 CNY and a price-to-book ratio of 12.73, indicating a premium valuation relative to its book value. The company's liquidit…
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.17, indicating a relatively low reliance on debt financing. However, its liquidity position is assessed as me…
ilShinBioBase maintains a strong liquidity position, as evidenced by its current ratio of 14.28, indicating that the company has significantly more current assets than current liabilities. The comp…
Structure and Liquidity BioToxTech maintains a market price of 2,910 KRW per share, with a market capitalization of 44.83 billion KRW. The company's price-to-book ratio is 0.89, indicating that the…
The company maintains a strong liquidity position, with a current ratio of 14.58, indicating a significant buffer of current assets over current liabilities. Its price-to-book ratio of 0.68 and pri…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. However, the free cash flow is negative at -148.41 million CNY,…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a strong equity position relative to liabilities. With a current ratio of 16.43, the company maint…
BTB Korea Co Ltd has a liquidity position that is characterized by a current ratio of 1.86, indicating that the company has 1.86 times more current assets than current liabilities. The company's ca…
Xunfei Healthcare Technology Co Ltd has a market capitalization of 9.72 billion CNY, with a current market price of 80.45 CNY per share. The company has no dilution risk, as the number of basic and…
Genertec Universal Medical Group Co Ltd has a basic and diluted share count of 2,014,204,924 shares outstanding, indicating no dilution from potential share issuance. However, liquidity risk could…
Honz Pharmaceutical Co Ltd has a market capitalization of 3.05 billion CNY and a price-to-book ratio of 3.39, indicating that the market values the company at a premium to its book value. The compa…
Biodyne maintains a strong liquidity position, with cash and equivalents amounting to 12,978,035,320 KRW, representing 28.9% of total assets. The company's liquidity FPT (free cash flow to total li…
Kanamic Network Co Ltd maintains a strong liquidity position, with a current ratio of 2.76 and a significant cash and equivalents balance of 3,327,111,000 JPY, indicating robust short-term financia…
MedFirst Healthcare Services Inc has a liquidity position that is below the industry median, with a current ratio of 0.76, indicating that the company's current assets are insufficient to cover its…
Genomics Bioscience & Technology Co Ltd has a basic and diluted share count of 72,448,000 shares, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be…
The company maintains a strong liquidity position, with a current ratio of 4.94 and cash and equivalents amounting to 825,731,000 JPY. Its debt-to-equity ratio is 0.13, indicating a conservative ca…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.